The findings indicate that the A20 p.P348L and Cezanne rs1230581026 variants are associated with low expression levels of A20/Cezanne, the accumulation of leukocytes and poor outcomes in B-ALL patients. This evidence concerns the gene TNFAIP3 and precursor B-cell acute lymphoblastic leukemia.